Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Heinz Remold, M.D., Dr.Rer.Nat

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Rheum./Immunol. Rm. 526B
75 Francis St
Boston MA 02115
Phone617/525-1061
Fax617/525-1010

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. IL-1ß Promotes Antimicrobial Immunity in Macrophages by Regulating TNFR Signaling and Caspase-3 Activation. J Immunol. 2013 Apr 15; 190(8):4196-204.
    View in: PubMed
  2. Divangahi M, Behar SM, Remold H. Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis. Adv Exp Med Biol. 2013; 783:103-20.
    View in: PubMed
  3. Martin CJ, Booty MG, Rosebrock TR, Nunes-Alves C, Desjardins DM, Keren I, Fortune SM, Remold HG, Behar SM. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe. 2012 Sep 13; 12(3):289-300.
    View in: PubMed
  4. Behar SM, Martin CJ, Nunes-Alves C, Divangahi M, Remold HG. Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis. Microbes Infect. 2011 Aug; 13(8-9):749-56.
    View in: PubMed
  5. Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol. 2011 May; 4(3):279-87.
    View in: PubMed
  6. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol. 2010 Sep; 8(9):668-74.
    View in: PubMed
  7. Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol. 2010 Aug; 11(8):751-8.
    View in: PubMed
  8. Boilard E, Lai Y, Larabee K, Balestrieri B, Ghomashchi F, Fujioka D, Gobezie R, Coblyn JS, Weinblatt ME, Massarotti EM, Thornhill TS, Divangahi M, Remold H, Lambeau G, Gelb MH, Arm JP, Lee DM. A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol Med. 2010 May; 2(5):172-87.
    View in: PubMed
  9. Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, Fortune S, Behar SM, Remold HG. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol. 2009 Aug; 10(8):899-906.
    View in: PubMed
  10. Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, Serhan CN, Behar SM, Remold HG. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008 Nov 24; 205(12):2791-801.
    View in: PubMed
  11. Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold HG. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol. 2008 Oct; 9(10):1189-97.
    View in: PubMed
  12. Lee J, Remold HG, Ieong MH, Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol. 2006 Apr 1; 176(7):4267-74.
    View in: PubMed
  13. Chen M, Gan H, Remold HG. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol. 2006 Mar 15; 176(6):3707-16.
    View in: PubMed
  14. Gan H, He X, Duan L, Mirabile-Levens E, Kornfeld H, Remold HG. Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential. J Infect Dis. 2005 Apr 15; 191(8):1292-300.
    View in: PubMed
  15. Duan L, Gan H, Golan DE, Remold HG. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis. J Immunol. 2002 Nov 1; 169(9):5181-7.
    View in: PubMed
  16. Duan L, Gan H, Arm J, Remold HG. Cytosolic phospholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra. J Immunol. 2001 Jun 15; 166(12):7469-76.
    View in: PubMed
  17. Fratazzi C, Manjunath N, Arbeit RD, Carini C, Gerken TA, Ardman B, Remold-O'Donnell E, Remold HG. A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med. 2000 Jul 17; 192(2):183-92.
    View in: PubMed
  18. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol. 2000 Feb 15; 164(4):2016-20.
    View in: PubMed
  19. Carroll JD, Wallace RC, Keane J, Remold HG, Arbeit RD. Identification of Mycobacterium avium DNA sequences that encode exported proteins by using phoA gene fusions. Tuber Lung Dis. 2000; 80(3):117-30.
    View in: PubMed
  20. Fratazzi C, Arbeit RD, Carini C, Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Macrophage apoptosis in mycobacterial infections. J Leukoc Biol. 1999 Nov; 66(5):763-4.
    View in: PubMed
  21. Balcewicz-Sablinska MK, Gan H, Remold HG. Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-alpha activity. J Infect Dis. 1999 Oct; 180(4):1230-7.
    View in: PubMed
  22. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol. 1998 Sep 1; 161(5):2636-41.
    View in: PubMed
  23. Cavinato RA, Remold H, Kipnis TL. Purification and variability in thrombin-like activity of Bothrops atrox venom from different geographic regions. Toxicon. 1998 Feb; 36(2):257-67.
    View in: PubMed
  24. von Reyn CF, Arbeit RD, Yeaman G, Waddell RD, Marsh BJ, Morin P, Modlin JF, Remold HG. Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. Clin Infect Dis. 1997 May; 24(5):843-8.
    View in: PubMed
  25. Fratazzi C, Arbeit RD, Carini C, Remold HG. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol. 1997 May 1; 158(9):4320-7.
    View in: PubMed
  26. Newman GW, Guarnaccia JR, Remold HG, Kazanjian PH. Cytokines enhance neutrophils from human immunodeficiency virus-negative donors and AIDS patients to inhibit the growth of Mycobacterium avium in vitro. J Infect Dis. 1997 Apr; 175(4):891-900.
    View in: PubMed
  27. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun. 1997 Jan; 65(1):298-304.
    View in: PubMed
  28. Gan H, Newman GW, Remold HG. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J Immunol. 1995 Aug 1; 155(3):1304-15.
    View in: PubMed
  29. Gan H, Newman GW, Remold HG. Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect Immun. 1995 May; 63(5):1921-6.
    View in: PubMed
  30. Newman GW, Guarnaccia JR, Vance EA, Wu JY, Remold HG, Kazanjian PH. Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS. 1994 Oct; 8(10):1413-9.
    View in: PubMed
  31. Newman GW, Balcewicz-Sablinska MK, Guarnaccia JR, Remold HG, Silberstein DS. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med. 1994 Jul 1; 180(1):359-63.
    View in: PubMed
  32. Kandil O, Fishman JA, Koziel H, Pinkston P, Rose RM, Remold HG. Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun. 1994 Feb; 62(2):644-50.
    View in: PubMed
  33. Newman GW, Kelley TG, Gan H, Kandil O, Newman MJ, Pinkston P, Rose RM, Remold HG. Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J Immunol. 1993 Aug 15; 151(4):2261-72.
    View in: PubMed
  34. Gan H, Newman G, McCarthy PL, Remold HG. TNF-alpha response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. J Immunol. 1993 Apr 1; 150(7):2892-900.
    View in: PubMed
  35. Xu X, Remold HG, Caulfield JP. Potential role for scavenger receptors of human monocytes in the killing of Schistosoma mansoni. Am J Pathol. 1993 Mar; 142(3):685-9.
    View in: PubMed
  36. Furlong ST, Mednis A, Remold HG. Interferon-gamma stimulates lipid metabolism in human monocytes. Cell Immunol. 1992 Aug; 143(1):108-17.
    View in: PubMed
  37. Filderman AE, Bruckner A, Kacinski BM, Deng N, Remold HG. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer Res. 1992 Jul 1; 52(13):3661-6.
    View in: PubMed
  38. Bruckner A, Filderman AE, Kirchheimer JC, Binder BR, Remold HG. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. Cancer Res. 1992 Jun 1; 52(11):3043-7.
    View in: PubMed
  39. Lehn M, Kandil O, Arena C, Rein MS, Remold HG. Interleukin-4 fails to inhibit interferon-gamma-induced activation of human colostral macrophages. Cell Immunol. 1992 Apr 15; 141(1):233-42.
    View in: PubMed
  40. Newman GW, Gan HX, McCarthy PL, Remold HG. Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-alpha and IL-6. J Immunol. 1991 Dec 1; 147(11):3942-8.
    View in: PubMed
  41. Kirchheimer JC, Remold HG, Wanivenhaus A, Binder BR. Increased proteolytic activity on the surface of monocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1991 Nov; 34(11):1430-3.
    View in: PubMed
  42. Gan HX, Ruef C, Hall BF, Tobin E, Remold HG, Mellors JW. Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses. 1991 Aug; 7(8):671-9.
    View in: PubMed
  43. Lehn M, Chiang CP, Remold HG, Swafford JR, Caulfield JP. Freshly isolated and cultured human monocytes obtained by plasmapheresis kill schistosomula of Schistosoma mansoni. Am J Pathol. 1991 Aug; 139(2):399-411.
    View in: PubMed
  44. Nong Y, Kandil O, Tobin EH, Rose RM, Remold HG. The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1. Cell Immunol. 1991 Jan; 132(1):10-6.
    View in: PubMed
  45. Engelhorn S, Bruckner A, Remold HG. A soluble factor produced by inoculation of human monocytes with Leishmania donovani promastigotes suppresses IFN-gamma-dependent monocyte activation. J Immunol. 1990 Oct 15; 145(8):2662-8.
    View in: PubMed
  46. Kirchheimer JC, Binder BR, Remold HG. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue. J Immunol. 1990 Sep 1; 145(5):1518-22.
    View in: PubMed
  47. Lehn M, Weiser WY, Engelhorn S, Gillis S, Remold HG. IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J Immunol. 1989 Nov 1; 143(9):3020-4.
    View in: PubMed
  48. Kirchheimer JC, Remold HG. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol. 1989 Oct 15; 143(8):2634-9.
    View in: PubMed
  49. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1989 Oct; 86(19):7522-6.
    View in: PubMed
  50. Kirchheimer JC, Remold HG. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 1989 Sep; 74(4):1396-402.
    View in: PubMed
  51. Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol. 1989 Jul 1; 143(1):45-9.
    View in: PubMed
  52. Nong YH, Remold-O'Donnell E, LeBien TW, Remold HG. A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J Exp Med. 1989 Jul 1; 170(1):259-67.
    View in: PubMed
  53. Toye P, Remold H. The influence of temperature and serum deprivation on the synthesis of heat-shock proteins and alpha and beta tubulin in promastigotes of Leishmania major. Mol Biochem Parasitol. 1989 Jun 1; 35(1):1-10.
    View in: PubMed
  54. Kirchheimer JC, Nong YH, Remold HG. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol. 1988 Dec 15; 141(12):4229-34.
    View in: PubMed
  55. Jensen WA, Rose RM, Burke RH, Anton K, Remold HG. Cytokine activation of antibacterial activity in human pulmonary macrophages: comparison of recombinant interferon-gamma and granulocyte-macrophage colony-stimulating factor. Cell Immunol. 1988 Dec; 117(2):369-77.
    View in: PubMed
  56. Remold HG, Mednis A, Hein A, Caulfield JP. Human monocyte-derived macrophages are lysed by schistosomula of Schistosoma mansoni and fail to kill the parasite after activation with interferon gamma. Am J Pathol. 1988 Apr; 131(1):146-55.
    View in: PubMed
  57. Van Niel A, Zacks SE, David JR, Remold HG, Weiser WY. Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF). Adv Exp Med Biol. 1988; 239:231-7.
    View in: PubMed
  58. Weiser WY, Van Niel A, Clark SC, David JR, Remold HG. Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med. 1987 Nov 1; 166(5):1436-46.
    View in: PubMed
  59. Vermeulen MW, David JR, Remold HG. Differential mRNA responses in human macrophages activated by interferon-gamma and muramyl dipeptide. J Immunol. 1987 Jul 1; 139(1):7-9.
    View in: PubMed
  60. Jensen WA, Rose RM, Wasserman AS, Kalb TH, Anton K, Remold HG. In vitro activation of the antibacterial activity of human pulmonary macrophages by recombinant gamma interferon. J Infect Dis. 1987 Mar; 155(3):574-7.
    View in: PubMed
  61. Gregory SA, Kornbluth RS, Helin H, Remold HG, Edgington TS. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol. 1986 Nov 15; 137(10):3231-9.
    View in: PubMed
  62. Rose RM, Wasserman AS, Weiser WY, Remold HG. Deficient responses of pulmonary macrophages from healthy smokers to antiviral lymphokines in vitro. J Infect Dis. 1986 Oct; 154(4):611-8.
    View in: PubMed
  63. Kawaguchi T, Golde DW, Mednis A, Bersch N, Clark S, Remold HG. T cell-derived migration-inhibitory factor and colony-stimulating factor share common structural elements. Blood. 1986 Jun; 67(6):1619-23.
    View in: PubMed
  64. Rose RM, Wasserman AS, Weiser WY, Remold HG. An acidic lymphokine distinct from interferon-gamma inhibits the replication of herpes simplex virus in human pulmonary macrophages. Cell Immunol. 1986 Feb; 97(2):397-406.
    View in: PubMed
  65. Weiser WY, David JR, Remold HG. Antigen-dependent heterogeneity of human migration inhibitory factor. Cell Immunol. 1985 Jul; 93(2):532-40.
    View in: PubMed
  66. Liu DY, Yu SF, Remold HG, David JR. Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor. Cell Immunol. 1985 Feb; 90(2):539-46.
    View in: PubMed
  67. Liu DY, Yu SF, Remold HG, David JR. Macrophage glycolipid receptors for human migration inhibitory factor (MIF): differentiated HL-60 cells exhibit MIF responsiveness and express surface glycolipids which both bind MIF and convert nonresponsive cells to responsiveness. Cell Immunol. 1985 Feb; 90(2):605-13.
    View in: PubMed
  68. Remold HG, Mednis AD. Migration inhibitory factor. Methods Enzymol. 1985; 116:379-94.
    View in: PubMed
  69. Buchmuller Y, Weiser WY, Remold HG. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages. Cell Immunol. 1985 Jan; 90(1):242-50.
    View in: PubMed
  70. Weiser WY, Remold HG, David JR. Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF. Cell Immunol. 1985 Jan; 90(1):167-78.
    View in: PubMed
  71. Liu DY, Yu SF, Miller PA, Remold HG, David JR. Glycolipid-dependent interaction between human migration-inhibitory factor and mononuclear phagocytes. Cell Immunol. 1984 Oct 15; 88(2):350-60.
    View in: PubMed
  72. Weiser WY, Remold HG, Block LH, David JR. Dissociation of human interferon-gamma-like activity from migration-inhibition factor. Cell Immunol. 1984 Oct 1; 88(1):109-22.
    View in: PubMed
  73. Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Welte K, Rubin BY, Murray HW. Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med. 1984 Aug 1; 160(2):600-5.
    View in: PubMed
  74. David JR, Remold HG, Liu DY, Weiser WY, David RA. Lymphokines and macrophages. Cell Immunol. 1983 Nov; 82(1):75-81.
    View in: PubMed
  75. Remold HG, Mednis A, Kawaguchi T, Bersch N, Golde DW. Production of migration-inhibitory factor by a human T-lymphoblast cell line. Cell Immunol. 1983 Jun; 78(2):305-13.
    View in: PubMed
  76. Prystowsky MB, Ely JM, Beller DI, Eisenberg L, Goldman J, Goldman M, Goldwasser E, Ihle J, Quintans J, Remold H, Vogel SN, Fitch FW. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol. 1982 Dec; 129(6):2337-44.
    View in: PubMed
  77. Liu DY, David JR, Remold HG. Glycolipid affinity purification of migration inhibitory factor. Nature. 1982 Mar 4; 296(5852):78-80.
    View in: PubMed
  78. Liu DY, Petschek KD, Remold HG, David JR. Isolation of a guinea pig macrophage glycolipid with the properties of the putative migration inhibitory factor receptor. J Biol Chem. 1982 Jan 10; 257(1):159-62.
    View in: PubMed
  79. Remold HG, Mednis AD. The effect of tunicamycin on the molecular heterogeneity of guinea pig migration inhibitory factor. Cell Immunol. 1982 Jan 1; 66(1):171-9.
    View in: PubMed
  80. Bout D, Kühner AL, Klimetzek V, Remold HG, David JR. Fractionation of murine macrophage inhibitory factor into two distinct species. Cell Immunol. 1981 Sep 1; 63(1):198-202.
    View in: PubMed
  81. Remold HG, McCarthy PL, Mednis AD. Purification of guinea pig pH 3 migration inhibitory factor. Proc Natl Acad Sci U S A. 1981 Jul; 78(7):4088-91.
    View in: PubMed
  82. Weiser WY, Greineder DK, Remold HG, David JR. Studies on human migration inhibitory factor: characterization of three molecular species. J Immunol. 1981 May; 126(5):1958-62.
    View in: PubMed
  83. Remold HG, Shaw JE, David JR. A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor. Cell Immunol. 1981 Feb; 58(1):175-87.
    View in: PubMed
  84. Klimetzek V, Remold HG. The murine bone marrow macrophage, a sensitive indicator cell for murine migration inhibitory factor and a new method for their harvest. Cell Immunol. 1980 Aug 1; 53(2):257-66.
    View in: PubMed
  85. Higgins TJ, Liu DY, Remold HG, David JR. Further characterization of the putative glycolipid receptor for MIF: role of fucose associated with an acidic glycolipid. Biochem Biophys Res Commun. 1980 Apr 29; 93(4):1259-65.
    View in: PubMed
  86. Liu DY, Petschek KD, Remold HG, David JR. Role of sialic acid in the macrophage glycolipid receptor for MIF. J Immunol. 1980 Apr; 124(4):2042-7.
    View in: PubMed
  87. Petty HR, Ware BR, Remold HG, Rocklin RE. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages. J Immunol. 1980 Jan; 124(1):381-7.
    View in: PubMed
  88. McCarthy PL, Shaw JE, Remold HG. The role of microtubules in the response of macrophages to MIF. Cell Immunol. 1979 Sep 1; 46(2):409-15.
    View in: PubMed
  89. Remold HG, Mednis AD. Two migration inhibitory factors differ in density and susceptibility to neuraminidase and proteinases. J Immunol. 1979 May; 122(5):1920-5.
    View in: PubMed
  90. Remold HG, Mednis AD, McCarthy PL. Studies of MIF and the role of macrophage associated esterases in the response of the macrophage to MIF. Adv Exp Med Biol. 1979; 114:465-8.
    View in: PubMed
  91. Heck L, Rosenberg R, Remold H. Purification and properties of guinea pig antithrombin III. Prep Biochem. 1979; 9(4):359-77.
    View in: PubMed
  92. Higgins TJ, Sabatino AP, Remold HG, David JR. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF). J Immunol. 1978 Sep; 121(3):880-6.
    View in: PubMed
  93. Heck LW, Remold-O'Donnell E, Remold HG. DFP-sensitive polypeptides of the guinea pig peritoneal macrophage. Biochem Biophys Res Commun. 1978 Aug 29; 83(4):1576-83.
    View in: PubMed
  94. Brown AP, Remold HG, Warren KS, David JR. Partial purification of antigens from eggs of Schistosoma mansoni that elicit delayed hypersensitivity. J Immunol. 1977 Oct; 119(4):1275-8.
    View in: PubMed
  95. Remold HG, Mednis AD. Two migration inhibitory factors with different chromatographic behavior and isoelectric points. J Immunol. 1977 Jun; 118(6):2015-9.
    View in: PubMed
  96. Butterworth AE, Remold HG, Houba V, David JR, Franks D, David PH, Sturrock RF. Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. J Immunol. 1977 Jun; 118(6):2230-6.
    View in: PubMed
  97. David JR, Butterworth AE, Remold HG, David PH, Houba V, Sturrock RF. Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. J Immunol. 1977 Jun; 118(6):2221-9.
    View in: PubMed
  98. Piessens WF, Remold HG, David JR. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes. J Immunol. 1977 Jun; 118(6):2078-82.
    View in: PubMed
  99. Remold HG. Chemical treatment of macrophages increases their responsiveness to migration inhibitory factor (MIF). J Immunol. 1977 Jan; 118(1):1-5.
    View in: PubMed
  100. Remold HG. Studies on the interaction of macrophage inhibitory factor (MIF) with the macrophage. Clin Immunol Immunopathol. 1975 Nov; 4(4):573-6.
    View in: PubMed
  101. Remold HG, Rosenberg RD. Enhancement of migration inhibitory factor activity by plasma esterase inhibitors. J Biol Chem. 1975 Aug 25; 250(16):6608-13.
    View in: PubMed
  102. Remold-O'Donnell E, Remold HG. The enhancement of macrophage adenylate cyclase by products of activated lymphocytes. J Biol Chem. 1974 Jun 10; 249(11):3622-7.
    View in: PubMed
  103. Remold HG. The enhancement of MIF activity by inhibition of macrophage associated esterases. J Immunol. 1974 Apr; 112(4):1571-7.
    View in: PubMed
  104. Remold HG. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF. J Exp Med. 1973 Nov 1; 138(5):1065-76.
    View in: PubMed
  105. Coyne JA, Remold HG, Rosenberg SA, David JR. Guinea pig lymphotoxin (LT). II. Physicochemical properties of LT produced by lymphocytes stimulated with antigen or concanavalin A: its differentiation from migration-inhibitory factor (MIF). J Immunol. 1973 Jun; 110(6):1630-7.
    View in: PubMed
  106. Nathan CF, Remold HG, David JR. Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med. 1973 Feb 1; 137(2):275-90.
    View in: PubMed
  107. Rocklin RE, Remold HG, David JR. Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol. 1972 Nov; 5(3):436-45.
    View in: PubMed
  108. Remold HG, David RA, David JR. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. J Immunol. 1972 Sep; 109(3):578-86.
    View in: PubMed
  109. Mednis A, Remold HG. A sensitive fluorometric assay for the determination of cathepsin D. Anal Biochem. 1972 Sep; 49(1):134-8.
    View in: PubMed
  110. David JR, Coyne JA, Rocklin RE, Nathan CF, Remold HG. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes. Transplant Proc. 1972 Jun; 4(2):241-2.
    View in: PubMed
  111. Meyers OL, Shoji M, Haber E, Remold HG, David JR. Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing macrophage inhibitory factor. Cell Immunol. 1972 Mar; 3(3):442-7.
    View in: PubMed
  112. Remold HG. Purification and characterization of lymphocyte mediators in cellular immunity: comparative studies on migration inhibitory factor (MIF) chemotactic factor for macrophages and lymphotoxin. Transplant Rev. 1972; 10:152-76.
    View in: PubMed
  113. Fasold H, Klappenberger J, Meyer C, Remold H. Bifunctional reagents for the crosslinking of proteins. Angew Chem Int Ed Engl. 1971 Nov; 10(11):795-801.
    View in: PubMed
  114. Remold HG, David JR. Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature. J Immunol. 1971 Oct; 107(4):1090-8.
    View in: PubMed
  115. Remold HG, Ward P, David JR. Characterization of migration inhibitory factor (MIF) and its separation from a chemotactic factor for monocytes. Int Arch Allergy Appl Immunol. 1971; 41(1):16-7.
    View in: PubMed
  116. Ward PA, Remold HG, David JR. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol. 1970 Jul; 1(2):162-74.
    View in: PubMed
  117. Remold HG, Katz AB, Haber E, David JR. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol. 1970 May; 1(1):133-45.
    View in: PubMed
  118. Ward PA, Remold HG, David JR. Leukotactic factor produced by sensitized lymphocytes. Science. 1969 Mar 7; 163(3871):1079-81.
    View in: PubMed
  119. Remold H, Fasold H, Staib F. Purification and characterization of a proteolytic enzyme from Candida albicans. Biochim Biophys Acta. 1968 Oct 8; 167(2):399-406.
    View in: PubMed
  120. Remold H, Zimmermann E. Stability of structures of human gamma-globulin. Arch Biochem Biophys. 1967 Apr; 120(1):35-41.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Remold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (493) concept(s)
_
Co-Authors
See all (25) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_